SAN DIEGO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results